scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by scPharmaceuticals Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for scPharmaceuticals Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Schaeffer Leonard D | Director | 0Indirect | Oct 7, 2025 | 1 |
| Veitinger Klaus R Dr | Director | – | Oct 7, 2025 | 1 |
| Tucker John H | President and CEO | 0 | Oct 7, 2025 | 1 |
| Hudson Frederick M. | Director | – | Oct 7, 2025 | 1 |
| Khattar Jack A. | Director | 0 | Oct 7, 2025 | 1 |
| Bonstein Sara | Director | – | Oct 7, 2025 | 1 |
| Agger Mette Kirstine | Director | – | Oct 7, 2025 | 1 |
| Baylor-Henry Minnie | Director | – | Oct 7, 2025 | 1 |
| Nokes Rachael | CFO and Treasurer | 0 | Oct 7, 2025 | 1 |
| Abraham William Tober | Director | – | Oct 7, 2025 | 1 |
| OrbiMed Advisors LLC | 10% Owner | 252,858Indirect | Aug 15, 2024 | 0 |
| OrbiMed Capital GP VI LLC | 10% Owner | 252,858Indirect | Aug 15, 2024 | 0 |
| OrbiMed Genesis GP LLC | 10% Owner | 252,858Indirect | Aug 15, 2024 | 0 |
| Rocklage Scott M | 10% Owner | 410,268Indirect | Oct 11, 2022 | 0 |
| Diekman John D | 10% Owner | 410,268Indirect | Oct 11, 2022 | 0 |
| 5AM Partners IV, LLC | 10% Owner | 410,268Indirect | Oct 11, 2022 | 0 |
| 5AM Ventures IV, L.P. | 10% Owner | 410,268Indirect | Oct 11, 2022 | 0 |
| 5AM Co-Investors IV, L.P. | 10% Owner | 410,268Indirect | Oct 11, 2022 | 0 |
| Schwab Andrew J. | 10% Owner | 410,268Indirect | Oct 11, 2022 | 0 |
| 5AM Opportunities I, L.P. | 10% Owner | 410,268Indirect | Oct 11, 2022 | 0 |
| 5AM Opportunities I (GP), LLC | 10% Owner | 410,268Indirect | Oct 11, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 (view filing) | Dec 3 | 3 days | Tucker John HPresident and CEO | PPurchase | +10.0K | $3.96 | +$39.6K | +27.1%47.0K after | |
| Dec 6, 2021 (view filing) | Dec 3 | 3 days | Khattar Jack A.Director | PPurchase | +5.00K | $3.91 | +$19.6K | New position5.00K after | |
| Apr 13, 2022 (view filing)4:51 PM ET | Apr 11 | 2 days | Rocklage Scott M and 7 others10% Owner | SSale | −270.0K | $5.00 | −$1.35M | −33.4%537.3K after | 3 lots |
| Sep 8, 2022 (view filing)7:58 PM ET | Sep 6-7 | 2 days | Rocklage Scott M and 7 others10% Owner | SSale | −226.6K | $4.84 | −$1.10M | −31.1%503.1K after | 6 lots |
| Oct 11, 2022 (view filing)7:10 PM ET | Oct 6-10 | 5 days | Rocklage Scott M and 7 others10% Owner | SSale | −600.0K | $4.15 | −$2.49M | −59.4%410.3K after | 6 lots |
| Nov 29, 2022 (view filing)4:36 PM ET | Nov 25 | 4 days | OrbiMed Advisors LLC and 2 others10% Owner | PPurchase | +762.4K | $5.25 | +$4.00M | +16.7%5.33M after | |
| Aug 15, 2024 (view filing)4:51 PM ET | Aug 13 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | PPurchase | +500.0K | $4.00 | +$2.00M | New position252.9K after | 2 lots |